Shih-Feng Cho, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
5 February 2015
We have found out two inadvertent errors in our article after publication. The corrections are as follows:
1. On Page 2, "Multiple myeloma patients and samples" in Method section.
Line 11)
Before correction: The diagnostic criteria, disease status and response to treatment were based on the criteria of the International Myeloma Working Group [17-19].
After correction: The diagnostic criteria, disease status and response to treatment were based on the criteria of the International Myeloma Working Group.
2. On page 3, "Real-time quantitative reverse transcription polymerase chain reaction (RT-PCR) analysis of MALAT1 expression" in Method section. The primer sequences of GAPDH were mistyped.
Line 11)
Before correction: ....the primer sequences of GAPDH were as follows: forward, 5’- AAAGTCCGCCATTTTGCCACT-3’; and reverse, 5’-CCAAATCGTTAGCGCTCCTT-3’.
After correction: ....the primer sequences of GAPDH were as follows: forward, 5’-AGCCACATCGCTCAGACAC-3'; and reverse, 5’-GCCCAATACGACCAAATCC-3'.
Correction of errors
5 February 2015
We have found out two inadvertent errors in our article after publication. The corrections are as follows:
1. On Page 2, "Multiple myeloma patients and samples" in Method section.
Line 11)
Before correction: The diagnostic criteria, disease status and response to treatment were based on the criteria of the International Myeloma Working Group [17-19].
After correction: The diagnostic criteria, disease status and response to treatment were based on the criteria of the International Myeloma Working Group.
2. On page 3, "Real-time quantitative reverse transcription polymerase chain reaction (RT-PCR) analysis of MALAT1 expression" in Method section. The primer sequences of GAPDH were mistyped.
Line 11)
Before correction: ....the primer sequences of GAPDH were as follows: forward, 5’- AAAGTCCGCCATTTTGCCACT-3’; and reverse, 5’-CCAAATCGTTAGCGCTCCTT-3’.
After correction: ....the primer sequences of GAPDH were as follows: forward, 5’-AGCCACATCGCTCAGACAC-3'; and reverse, 5’-GCCCAATACGACCAAATCC-3'.
Competing interests
No competing interests